Medical News

RSS

Boston Scientific initiates study to compare PROMUS Element Stent to XIENCE PRIME Stent System

Boston Scientific Corporation today announced the initiation of the PLATINUM PLUS clinical trial, an investigator-sponsored research (ISR) study designed to compare the performance of the PROMUS® Element™ Everolimus-Eluting Coronary Stent System to the XIENCE PRIME™ Everolimus-Eluting Coronary Stent System.

26 May 2010

ACOEM publishes new medical treatment guidelines for hip and groin disorders

The American College of Occupational and Environmental Medicine today published new medical treatment guidelines for providing care to workers with injuries and disorders of the hip and groin. The new guidelines, which represent the latest chapter in ACOEM's comprehensive publication Occupational Medicine Practice Guidelines, are available on line now via ACOEM's APG-I web application; a print version will be available in the fall of 2010, when the Third Edition hard-copy of Occupational Medicine Practice Guidelines is published.

26 May 2010

Positive results from 3 year follow-up of BPH patients treated with NX-1207 in Study NX02-0016

Nymox Pharmaceutical Corporation is pleased to report positive new results from the 30-36 month follow-up study of patients treated with NX-1207 in Study NX02-0016. The initial study, completed in the U.S. in 2007, reached statistical significance in Intent-to-Treat Primary Efficacy outcomes at 90 days and 6 months post-treatment with NX-1207 2.5 mg.

26 May 2010

EIRMC, West Valley Medical Center to continue to serve Humana's Medicare Advantage members

Eastern Idaho Regional Medical Center (EIRMC), a full-service regional medical center in Idaho Falls, and West Valley Medical Center, a community hospital in Caldwell, will continue to provide in-network medical care to all Medicare Advantage members enrolled in plans offered by Humana, under terms of a renewal agreement announced today.

26 May 2010

Increasing levels of GGA3 protein prevent accumulation of enzyme linked to Alzheimer's disease

Researchers at Tufts University School of Medicine have zeroed in on a protein that may play a role in the progression of Alzheimer's disease. The team found that increasing levels of the protein (called GGA3) prevented the accumulation of an enzyme linked to Alzheimer's. The strategy may lead to new treatments for the neurodegenerative disease.

26 May 2010

ReVision Optics receives $35 million in capital funding

ReVision Optics, Inc. (RVO), an ophthalmic surgical products company, recently received $35 million in capital funding. The Lake Forest, Calif.-based firm specializes in the research, development and manufacturing of custom products to correct and maintain near vision.

26 May 2010

Workplace wellness programs improve employer's bottom line

"Who has time?" is a frequent question in response to the suggestion of a medical check-up. Job demands aren't becoming easier to meet in this challenging economy. And there is always a "to-do" list waiting at home. Naturally employees feel these pressures.

26 May 2010

Researchers present more findings for microbicides, prep at M2010 conference

Researchers on Monday at the International Microbicides Conference in Pittsburgh continued to present data on HIV prevention research, Reuters reports. The news service outlines several prevention methods being researched, including an intravaginal ring that over time releases two antiretrovirals - dapivirine and maraviroc - for up to a month, and a vaginal tablet that time-releases the antiretrovirals dapivirine and DS003 for up to 12 hours.

26 May 2010

Shire announces study results of Vyvanse Capsules CII for treatment of ADHD in adolescents

Shire plc, the global specialty biopharmaceutical company, today announced the results of a study evaluating the safety and efficacy of Vyvanse (lisdexamfetamine dimesylate) Capsules CII for the treatment of Attention Deficit Hyperactivity Disorder in adolescents aged 13 to 17 years.

26 May 2010

AHF urges Obama to address growing ADAP crisis

As many states across the nation face budget and funding shortfalls that are crippling their lifesaving AIDS Drug Assistance Programs (ADAPs), AIDS Healthcare Foundation (AHF), the largest global AIDS organization, is urging President Barack Obama to redirect a portion of unspent stimulus funds in the Health and Human Services Department in order to address the growing ADAP crisis.

26 May 2010

Accenture announces enhanced insurance industry solutions

Accenture has unveiled newly enhanced claims and policy administration solutions designed to help property and casualty (P&C) and life insurers focus on operational efficiency and profitable growth by enhancing process automation and multi-channel distribution integration.

26 May 2010

Positive results reported from Phase IIa clinical trial of intranasal oxytocin for CDH

Trigemina, Inc., a Mountain View based privately-held biopharmaceutical company, reports positive results from a time-based interim analysis of its Phase IIa clinical trial in Chronic Daily Headache. The trial is a collaborative effort between Trigemina and Dr. Egilius Spierings of MedVadis Research Corporation located outside of Boston. The study compares intranasal oxytocin with placebo in patients suffering from CDH.

26 May 2010

G7 aid delivers 'impressive results,' commitment falls short of 2005 pledge

According to an annual ONE report, which tracks progress on aid commitments made at the 2005 G8 summit in Gleneagles, Scotland, the G7 - Canada, France, Germany, Italy, Japan, the United Kingdom and the U.S. - is "on track to deliver 61 percent of their combined commitments to sub-Saharan Africa, or $13.7 billion of the $22.6 billion increase they promised," allAfrica.com reports.

26 May 2010

Visually-guided laser-balloon catheter stops abnormal electrical pulses in patients with irregular heartbeats

A new treatment known as a visually-guided laser-balloon catheter successfully interrupted abnormal electrical pulses in patients and pigs with intermittent, irregular heartbeats, in a study reported in Circulation: Arrhythmia and Electrophysiology, a journal of the American Heart Association.

26 May 2010

Study confirms effectiveness of CT for diagnosis of appendicitis

When CT results suggest appendicitis, but a patient's symptoms are inconsistent with the acute condition, physicians should consider a diagnosis of chronic or recurrent appendicitis and surgical treatment, according to a new study published in the online edition and July printed issue of the journal Radiology.

26 May 2010

NEVO Sirolimus-eluting Coronary Stent demonstrates safety and efficacy outcomes at 12 months

At 12 months the NEVO™ Sirolimus-eluting Coronary Stent has continued to demonstrate excellent safety and efficacy outcomes compared to Taxus® Liberte® according to new data presented today from the NEVO™ RES-I clinical trial. These results were presented as a late breaking trial at EuroPCR, the leading medical conference in Europe for physicians specializing in interventional cardiovascular medicine.

26 May 2010

Targeted enrollment in Phase IIb trial for EpiCept NP-1 in CPN attained: EpiCept

EpiCept Corporation today announced that the targeted enrollment in a Phase IIb trial for EpiCept NP-1 in chemotherapy-induced peripheral neuropathy has been attained. The trial is being conducted by National Cancer Institute -funded Community Clinical Oncology Program.

26 May 2010

NIDDK awards Albert Einstein College of Medicine $9.5M for continuation of Diabetes Research and Training Center

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) has awarded Albert Einstein College of Medicine of Yeshiva University a five-year, $9.5 million grant for the continuation of its Diabetes Research and Training Center (DRTC). The DRTC was also awarded a $632,000 supplemental grant for equipment and additional pilot and feasibility studies through the American Recovery and Reinvestment Act (ARRA), bringing total NIH support to $10,177,000.

26 May 2010

East African examines 10-year research program to address agriculture, food security, climate change in rural areas

The East African examines the Climate Change, Agriculture and Food Security program, a 10-year research collaboration between the Consultative Group on International Agriculture Research and the Earth System Science Partnership that aims to help rural communities address these issues (Butunyi, 5/24).

26 May 2010

Defect in cellular pathways provides new explanation for earliest stages of craniosynostosis in newborns

University of Rochester Medical Center scientists discovered a defect in cellular pathways that provides a new explanation for the earliest stages of abnormal skull development in newborns, known as craniosynostosis.

26 May 2010

Medical News

Boston Scientific initiates study to compare PROMUS Element Stent to XIENCE PRIME Stent System

ACOEM publishes new medical treatment guidelines for hip and groin disorders

Positive results from 3 year follow-up of BPH patients treated with NX-1207 in Study NX02-0016

EIRMC, West Valley Medical Center to continue to serve Humana's Medicare Advantage members

Increasing levels of GGA3 protein prevent accumulation of enzyme linked to Alzheimer's disease

ReVision Optics receives $35 million in capital funding

Workplace wellness programs improve employer's bottom line

Researchers present more findings for microbicides, prep at M2010 conference

Shire announces study results of Vyvanse Capsules CII for treatment of ADHD in adolescents

AHF urges Obama to address growing ADAP crisis

Accenture announces enhanced insurance industry solutions

Positive results reported from Phase IIa clinical trial of intranasal oxytocin for CDH

G7 aid delivers 'impressive results,' commitment falls short of 2005 pledge

Visually-guided laser-balloon catheter stops abnormal electrical pulses in patients with irregular heartbeats

Study confirms effectiveness of CT for diagnosis of appendicitis

NEVO Sirolimus-eluting Coronary Stent demonstrates safety and efficacy outcomes at 12 months

Targeted enrollment in Phase IIb trial for EpiCept NP-1 in CPN attained: EpiCept

NIDDK awards Albert Einstein College of Medicine $9.5M for continuation of Diabetes Research and Training Center

East African examines 10-year research program to address agriculture, food security, climate change in rural areas

Defect in cellular pathways provides new explanation for earliest stages of craniosynostosis in newborns

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News